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Abstract
We synthesized and characterized a new tagging reagent, (3R,4S)-1-(4-
(aminomethyl)phenylsulfonyl)pyrrolidine-3,4-diol (APPD), for the selective fluorogenic
derivatization of 3-nitrotyrosine (3-NT) residues in peptides (after reduction to 3-aminotyrosine)
and affinity enrichment. The synthetic 3-NT-containing peptide, FSAY(3-NO2)LER, was
employed as a model for method validation. Further, this derivatization protocol was successfully
tested for analysis of 3-NT-containing proteins exposed to peroxynitrite in the total protein lysate
of cultured C2C12 cells. The quantitation of 3-NT content in samples was achieved through either
fluorescence spectrometry or boronate affinity chromatography with detection by specific
fluorescence (excitation and emission wavelengths of 360 and 510 nm, respectively); the
respective limits of detection were 95 and 68 nM (19 and 13 pmol total amount) of 3-NT.
Importantly, the derivatized peptides show a strong retention on a synthetic boronate affinity
column, containing sulfonamide-phenylboronic acid, under mild chromatographic conditions,
affording a route to separate the derivatized peptides from large amounts (milligrams) of non-
derivatized peptides, and to enrich them for fluorescent detection and MS identification. Tandem
MS analysis identified chemical structures of peptide 3-NT fluorescent derivatives and revealed
that the fluorescent derivatives undergo efficient backbone fragmentations, permitting sequence-
specific identification of protein nitration at low concentrations of 3-NT in complex protein
mixtures.
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Protein tyrosine (Tyr) nitration to 3-nitrotyrosine (3-NT) is a nitric oxide (NO)-dependent
post-translational modification (PTM) associated with a number of diseases and biological
aging [1–5]. In order to correlate protein Tyr nitration mechanistically with specific
physiological and pathological conditions, it is important to identify protein target sequences
and to quantify protein-3-NT residues on these proteins. Several proteomic studies have
provided important information about protein targets for nitration in vivo [6–11]. However,
it appears that most of these approaches only yielded data covering a small fraction of
possible protein targets. Some strategies for the enrichment of 3-NT-containing peptides and
proteins have been developed, based on the reduction of 3-NT to 3-aminotyrosine (3-AT) as
a critical step, followed by either differential detection of 3-AT (instead of 3-NT) [11] or the
reaction of 3-AT with N-hydroxysuccinimide esters coupled to biotin [12] or a functional
group available for further derivatization [13]. However these derivatization approaches can
suffer from side reactions of N-hydroxysuccinimide esters with other primary amines
especially when the abundance of 3-NT is low. Moreover, the published methods [11–13] do
not allow for quantification other than through integration of mass spectrometric signals.
Therefore, we have developed a selective derivatization strategy of 3-AT with benzylamine,
which yields a highly fluorescent benzoxazole product available for quantitative assessment
by fluorescence spectrometry or HPLC with fluorescence detection [14]. This reagent does
not form a fluorescent product with either peptide N-terminal or Lys amino groups, and,
further, allows for relative quantification of original 3-NT-containing peptides through
stable isotopic labeling using a couple of “light” and “heavy” reagents [14]. The
chromatographic properties of benzylamine-tagged peptides can be controlled through
substituents on the original benzylamine, as demonstrated in a comparison between
benzylamine and 4-(aminomethyl)benzenesulfonic acid (ABS) [15]. We have now extended
the derivatization strategy to incorporate a functional group for the affinity-enrichment of 3-
NT-containing peptides, using a novel synthetic benzylamine derivative with a substituent
suitable for boronate affinity chromatography. Boronate affinity separation is based on the
pH-dependent formation of a pentacyclic complex of boronic acid with cis-diol compounds,
which has been employed in the separation of biological molecules, such as catechols,
nucleotides, nucleosides, carbohydrates, glycoproteins and some enzymes [16–20].
Recently, some tagging methods for specific residues have been reported for the separation
of peptides/proteins by boronate affinity chromatography. For example, the guanidine group
of arginine in peptides/proteins was covalently modified with 2,3-butanedione to yield cis-
diol containing triazolidine derivatives amenable for separation by boronate affinity [21]. In
this paper we describe the synthesis and application of (3R,4S)-1-(4-
(aminomethyl)phenylsulfonyl) pyrrolidine-3,4-diol (APPD) for fluorogenic derivatization
and boronate affinity enrichment of 3-NT in proteins and peptides. Our results suggest that
the method is suitable for quantitative proteomic analysis of protein nitration.
Materials and methods
Reagents
All chemicals for the synthesis of APPD were purchased from Sigma-Aldrich (St. Louis,
MO, USA) and used as received unless otherwise stated. Solvents were of HPLC purity.
Synthesis and characterization of standard 3-NT-containing peptide
A 3-NT-containing peptide, representing the partial sequence of mouse muscle
phosphorylase b, 545FSAY(NO2)LER551, was synthesized on an ACT 90 (Advanced
ChemTech, Louisville, KY) instrument by means of a solid phase technique using Fmoc-
protected amino acids and 3-NT purchased from Bachem Bioscience (King of Prussia, PA).
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The peptide was purified by semi-preparative HPLC performed on a Summit HPLC system
(Dionex Corp., Sunnyvale, CA). Peptide purity was >99%, as characterized by ESI-MS and
analytical reverse-phase HPLC analyses.
Synthesis of APPD tagging reagent
The synthetic steps for the synthesis of APPD are summarized in Figure 1.
(3R,4S)-1-benzyl-3,4-dihydroxypyrrolidine-2,5-dione 1—N-benzylmaleimide was
prepared by reaction of benzylamine with maleic anhydride followed by dehydration in
acetic anhydride containing sodium acetate. The crude product was purified by dissolving in
ethanol and subsequently precipitating with water (yield: 45%). To a stirred solution of 6.5 g
of N-methylmorpholine N-oxide and 6 ml of osmium tetraoxide solution (2.5 wt% in tert-
butyl alcohol) in a mixture of 50 ml of acetone and 10 ml of deionized water were added
10.0 g N-benzylmaleimide (osmium tetraoxide is toxic [22,23] and must be handled and
disposed of with appropriate precautions). The mixture was stirred at 45°C for 24 h. After
the reaction mixture was cooled to room temperature, 3.0 g Na2SO3 were added and stirred
for 30 min, and filtered with celite through a sintered glass funnel. The filtrate was
concentrated by evaporation under reduced pressure and extracted with 3 × 50 ml of ethyl
acetate. The combined organic extract was dried over Na2SO4 and evaporated under reduced
pressure, affording a deep brown gum which was allowed to granulate for 4 hours at room
temperature. The resulting solid was washed with 30 ml of chloroform and dried in vacuum
to give compound 1 (5.5 g, 46% yield) as white powder: mp 125–127°C; 1H NMR (DMSO-
d6): δ 7.32 ~ 7.24 (m, 5H), 6.02 (d, 2H), 4.55 (s, 2H), 4.42 (d, 2H).
(3aR,6aS)-5-benzyl-2,2-dimethyl-3aH-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H,6aH)-
dione 2—To a slurry of 8.5 g of 1 in 40 ml of 2,2-dimethyloxypropane was added 0.02 g of
p-toluenesulfonic acid and the mixture was stirred at room temperature for 10 h. The
reaction mixture was then stirred with 0.5 g of sodium bicarbonate for 10 min, filtered, and
concentrated by evaporation under reduced pressure. The residue was dissolved in 80 ml of
chloroform and washed with 1 M Na2CO3 solution, dried over Na2SO4 and evaporated
under reduced pressure. The solid that formed was washed with petroleum ether and dried
under vacuum overnight, affording product 2 (9.6 g, 95% yield) as white powder. NMR
(CDCl3): δ 7.41 ~ 7.28 (m, 5H), 4.86 (s, 2H), 4.69 (s, 2H), 1.43 (s, 3H), 1.30 (s, 3H).
(3aR,6aS)-5-benzyl-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole 3—
To a solution of 9.5 g of compound 2 in 20 ml of diethyl ether was added in portions a total
of 5.0 g of LiAlH4 (LiAlH4 must be handled with appropriate precautions!). The slurry was
heated to 80°C and refluxed for 24 h, and then cooled in an ice-bath. To the reaction mixture
were slowly added 30 ml of ethyl acetate and then 20 ml of 30% NaOH solution under
stirring. After 30 min, the mixture was filtered, and the filtration cake was washed twice
with 30 ml of ethyl acetate. The combined organic layer was dried over Na2SO4 and
evaporated under reduced pressure to give product 3 as pale yellow oil. Yield: 8.2 g,
92%. 1H NMR (CDCl3): δ 7.36 ~ 7.25 (m, 5H), 4.66 (d, 2H), 3.63 (s, 2H), 3.0 (dd, 2H), 2.1
(dd, 2H), 1.59 (s, 3H), 1.34 (s, 3H).
(3aR,6aS)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole 4—To a stirred
solution of 8.0 g of compound 3 in 50 ml of methanol was carefully added 1.5 g of 20%
Pd(OH)2/C catalyst under argon. The slurry mixture was hydrogenated at 20 psi for 18 h at
room temperature, and filtered to remove the catalyst (the hydrogenation must be carried out
with appropriate care), and the filtration cake was washed with 20 ml of methanol. The
combined organic solutions were evaporated under reduced pressure. The residue was
dissolved in 50 ml of diethyl ether, and 10 ml of 1.0 M HCl in ether were added. The
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crystalline precipitate that formed was collected by filtration, washed with ether and dried
under vacuum to give compound 4 (5.42 g, 89%) as a white powder. 1H NMR (DMSO-d6):
δ 4.65 (d, 2H), 3.08 (dd, 2H), 2.50 (dd, 2H), 1.44 (s, 3H), 1.31 (s, 3H).
4-(((3aR,6aS)-2,2-dimethyldihydro-3aH-[1,3]dioxolo[4,5-c]pyrrol-5(4H)-
yl)sulfinyl)benzonitrile 5—To a solution of 3.0 g of 4 in 50 ml of acetonitrile were added
5.0 ml of triethylamine and 3.4 g of 4-cyanobenzene-1-sulfonyl chloride, and the mixture
was stirred for 1 h and subsequently filtered. The filtrate was washed with 10 ml of a
saturated aqueous solution of NaCl, and evaporated under reduced pressure to give product
5 (5.6 g, 89% yield) as a white solid. 1H NMR (DMSO-d6): δ 7.92 (d, 2H), 7.82 (d, 2H),
4.64 (s, 2H), 3.59 (dd, 2H), 2.97 (dd, 2H), 1.29 (s, 3H), 1.22 (s, 3H).
(3R,4S)-1-((4-(aminomethyl)phenyl)sulfonyl)pyrrolidine-3,4-diol (APPD) 6—To a
solution of 5.0 g of compound 5 in 50 ml of methanol containing 1 ml of acetic acid was
carefully added 0.5 g of 10% Pd/C catalyst. The mixture was hydrogenated at 40 psi for 18 h
at room temperature, and subsequently filtered to remove the catalyst (the hydrogenation
must be carried out with appropriate care); the filtration cake was washed with 20 ml of
methanol. The combined organic solutions were evaporated under reduced pressure. To the
residue was added 40 ml of 2 M HCl in aqueous solution, and the mixture was heated to
70°C and stirred for 2 hours. The solvent was removed by evaporation under reduced
pressure to give product 6, which was washed with chloroform and ether, and dried under
vacuum (3.4g, 68%). 1H-NMR (D2O): δ 7.94 (d, 2H), 7.71 (d, 2H), 4.31 (s, 2H), 4.14 (t,
2H), 3.53 (dd, 2H), 3.23 (dd, 2H). 13C-NMR (50% CD3OD/50% H2O): 139.58 (s, 1C),
137.22 (s, 1C), 130.83 (s, 2C), 129.16 (s, 2C), 71.47 (s, 2C), 52.68 (s, 2C), 43.62 (s, 1C).
MS (ES+, 20 eV): m/z 273.06 ([M+H]+), Calculated for C11H16N2O4S: 272.08.
Preparation of peroxynitrite for protein nitration in vitro
Peroxynitrite (ONOO−) was prepared by the ozonolysis of sodium azide solutions as
described earlier [24]; the ONOO− content in stock solutions containing 0.1% NaOH was
quantified using ε302=1,670 M−1cm−1 [4].
Protein nitration in vitro
Prior to protein tyrosine nitration, 1 mg/mL (~10 µM) rabbit muscle phosphorylase b (Ph-b)
(Prozyme, San Leandro, CA) in a buffer containing 1% (w/v) SDS, 50 mM NH4HCO3, pH
7.8, was reductively alkylated by incubation with 2 mM DTT for 30 min at 50°C followed
by the addition of iodoacetic acid (IAA) at a final concentration of 5 mM and incubation for
an additional 30 min at room temperature. The alkylated protein was separated from
unreacted compounds and side products by precipitation in ten volumes of cold ethanol for 4
h at −20°C followed by centrifugation at 14,000 g for 2 min. This step was necessary to
remove I−, which otherwise could react with ONOO− to form I2 leading to Tyr iodination as
assessed through the formation of iodo-Tyr modified peptides by LC-MS/MS analysis (data
not shown). Reconstituted 100-µL (100-µg) Ph-b aliquots in 0.1 M phosphate buffer
containing 1% SDS were then nitrated by the addition of 10 µL alkaline stock solution of
ONOO− (final concentration of 3 mM) while vortexing to yield ca. 100 µM protein 3-NT.
The content of 3-NT on Ph-b was determined by UV-spectroscopy (ε430=4,400 M−1cm−1 at
pH>9) using non-nitrated protein samples for background control [4]. Ph-b samples
containing desired concentrations of 3-NT were prepared by mixing of nitrated and control
protein at specific ratios.
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Protein nitration in cell culture
C2C12 murine myoblasts were grown in Petri dishes as monolayers to ca. 50% confluence
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum and penicillin/streptomycin at 37°C and 5% CO2. The resulting monolayers were
washed with PBS, trypsinized, washed with DMEM and PBS, and collected by
centrifugation at 500 g for 2 min. A cell suspension in PBS containing 1.5 mg/ml protein
was exposed to peroxynitrite (final concentration 3 mM) under vortexing for 5 seconds in
1.5-mL Eppendorf tubes. Cells were lysed by the addition of 1% SDS to PBS buffer and
sonication for 30 sec. at 10% power output of the probe sonicator Sonic Dismembrator 500
(Fisher Scientific, Pittsburgh, PA). The supernatant was used for the analysis of protein
nitration.
Preparation of protein tryptic digests
Following the nitration, C2C12 cell proteins were subjected to reductive alkylation of Cys
residues (in the presence of 1% SDS) and cold ethanol precipitation as described above for
phosphorylase b sample preparation. After centrifugation, protein pellets were collected and
reconstituted in digestion buffer containing 50 mM NH4HCO3 (pH 7.8), 10% (v/v)
acetonitrile, and trypsin (sequence grade from Promega, Madison, WI) at a 1:20 (w/w) ratio
to proteins. Digestion was carried out overnight at 37°C.
Derivatization of 3-NT peptides with APPD
Prior to APPD tagging, 3-NT peptides were reduced to 3-AT peptides by incubation with 10
mM sodium dithionite (Na2S2O4) for 2 min at room temperature and the resultant 3-AT-
containing peptides immediately separated from the reagent by reverse-phase HPLC (see
below). Tagging with APPD was carried out in 0.1 M sodium phosphate buffer (pH 9.0) in
the presence of K3Fe(CN)6. Concentrations of the reagents were experimentally evaluated
(see below). A typical procedure for the derivatization would be as follows: to 0.25 ml of
peptide solution in 0.1 M PBS (pH 9.0) 10 mM APPD and 100 µM K3Fe(CN)6 are added
and the reaction mixture is incubated at room temperature for 1 h. The reaction was
monitored by fluorescence spectrometry and reversed-phase HPLC with UV and
fluorescence detection.
Fluorescence measurements
After derivatization, fluorescence spectra were measured in 0.5-mL 1-cm light-pass
fluorescence cuvettes (Hellma, Plainview, NY) using a Shimadzu RF-5000U fluorescence
spectrophotometer with excitation and emission band widths set at 5 nm. Spectra were then
digitized and fluorescence intensities were calculated from the spectra.
Reverse-phase HPLC
Synthetic and tryptic peptides, and their derivatives, were separated by reverse-phase HPLC
using Vydac C18 columns and acetonitrile (ACN) gradients. Desalting of peptides after 3-
NT reduction to 3-AT was achieved on guard columns (4.6 mm ID × 10 mm length)
equilibrated with 0.01% aqueous trifluoroacetic acid (TFA) (mobile phase A), and after
washing for at least 5 min under control of the baseline with UV detection, peptides were
eluted by a steep linear gradient increasing ACN in 0.1% TFA from 0 to 80% (v/v) within 5
min., followed by an additional 5 min. elution with 80% (v/v) ACN in 0.1% aqueous TFA.
Fractions containing peptides (from 6 to 10 min.) were collected and dried in a speed-vac
before reconstitution in the media compatible with the next analysis or derivatization step.
For analytical HPLC of APPD-tagged FSAY*LER (here Y* denominates various
derivatives of the tyrosine residue, such as 3-NT, 3-AT, and derivatization products)
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samples were injected onto a Vydac C18 column (4.6 mm ID × 250 mm length) equilibrated
with 10%ACN/90%H2O/0.1%TFA (v/v/v), and peptides were separated by a linear increase
of ACN in the mobile phase (1%/min) followed by a washing step for 10 min at 80% ACN.
UV and fluorescence detection were achieved using a photodiode array (PDA) detector
SPD-M10AVP and fluorescence detector RF-10AXL (both from Shimadzu USA
Manufacturing, Canby, OR), respectively.
Boronate affinity chromatography
Sulfonamide-phenylboronic acid-functionalized (0.45 mmol/g) silica gel (Nucleosil, 5 µm,
500 Å, Marcherey-Nagel, Düren) was prepared as described [25] and used as boronate
affinity solid phase in this work. The solid phase was slurry packed (0.5 g silica phase in 50
ml methanol) into an empty stainless steel chromatography column (4.6 mm i.d. × 50 mm)
under a pressure of 8000 p.s.i. with an air-driven fluid pump (Haskel, Burbank, CA).
Boronate affinity chromatography was conducted using 50 mM NH4HCO3 buffer (pH 7.8)
as mobile phase for binding of the APPD-tagged peptides and water (pH~5.8) for elution, in
the presence or in the absence of 30% (v/v) ACN. The flow rate was 1.0 mL/min, and the
effluent was monitored with UV and fluorescence detection. A TSK-Gel Boronate-5PW
column (1000Å, 10µ, 7.5 mm i.d. × 75 mm length) was purchased from Tosoh Biosciences,
Montgomeryville, PA.
MALDI-TOF Mass Spectrometry
For MALDI-TOF MS analysis, either desalted (using C18 ZipTips, Millipore Co., Bedford,
MA) or non-treated samples were directly applied onto the stainless steel sample plate with
2 µl of 50% (v/v) acetonitrile/0.1% TFA saturated with α-cyano-4-hydroxycinnamic acid.
Mass spectra were acquired in the mass range between 500 and 3000 amu on a Voyager-DE
STR mass spectrometer (PerSeptive Biosystems, Framingham, MA) equipped with a 337
nm nitrogen laser. The instrument was operated in the positive reflector mode with the
following parameters: accelerating voltage: 20,000 V; grid voltage: 70–75%; mirror voltage
ratio: 1.12; guide wire: 0.02%; extraction delay time: 150 nsec.
Capillary liquid chromatography-mass spectrometry analysis for protein mapping
Samples were desalted using Oasis™ HLB columns (Waters Corporation, Milford, MA) as
suggested by the manufacturer, and introduced into an LTQ-FT hybrid linear quadrupole ion
trap Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer
(ThermoFinnigan, Bremen, Germany) via capillary liquid chromatography (capLC),
analogous to a published procedure [26]. In brief, peptides were separated on a reverse-
phase LC Packings PepMap C18 column (0.300 × 150 mm) at a flow rate of 10 µL/min with
a linear gradient rising from 0 to 65% acetonitrile in 0.06% aqueous formic acid over a
period of 55 min using an LC Packing Ultimate Chromatograph (Dionex). LC-MS
experiments were performed in a data-dependent acquisition manner using the Xcalibur 2.0
software (Thermo Scientific). The five most intensive precursor ions in a survey MS1
spectrum acquired in the Fourier transform-ion cyclotron resonance over a mass range of
300–2000 m/z were selected and fragmented in the linear ion trap by collision-induced
dissociation. The ion selection threshold was 500 counts.
Raw experimental files were processed by TurboSequest search using BioWorks 3.2
(ThermoFinnigan). The resulted MS/MS peak lists in dta format were combined within each
experiment using an in-house written Perl script and submitted for peptide/protein
identification to the Mascot 2.2 (Matrix Science, London, UK) database-searching program
using a most recent Swiss-Prot or IPI mouse database with a fragment ion mass tolerance of
0.20 a.m.u. and a parent ion tolerance of 10 ppm. Trypsin specificity and up to 2 missed
cleavage sites were used in the search parameters. In order to find all possible products
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(delta masses) of derivatization reaction between APPD and nitropeptides we used the P-
Mod software ([27] to map experimental data. Based on those data, variable protein
modifications for Sequest and Mascot searches were set to be +16 on M (oxidation), +15 on
Y (aminotyrosine), +45 on Y (nitration), +264 on Y, +281 on Y, +536 on Y (APPD
derivatives). An additional shift of +80 on Y for all the above Y modifications was
considered to take into account a potential sulfation of tyrosine residues during the reduction
of 3-nitrotyrosine to 3-aminotyrosine with sodium dithionite. Carboxymethylation of
cysteine residues was considered a fixed modification.
Sequest and Mascot results were imported into a Scaffold 3.0 software (Proteome Software
Inc., Potland, OR; free viewer is available at http://www.proteomesoftware.com) for
analyzing with the X!Tandem search algorithm and statistical validation of peptide/protein
identities. Peptide identifications were accepted if they could be established at greater than
95% probability as specified by the Peptide Prophet algorithm as described [28]. Protein
identifications were accepted if they could be established at >95% probability and contained
at least 2 identified peptides. Protein probabilities were assigned by the Protein Prophet
algorithm [29]. Proteins that contained similar peptides and could not be differentiated based
on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
Statistical analysis
For quantitative analysis, all measurements were performed in triplicate, and the data
presented as mean ± standard deviation. The limits of detection were calculated from
concentration dependencies including at least 7 data points over a limited concentration
range as LOD=3sB/b, where sB (the standard error of blank) was obtained from the linear
regression analysis (y=a+bx) as a standard deviation of y, and b is the slope of the best linear
fit line from the linear regression [30].
Results
Synthesis of Tagging Reagent (APPD)
The synthetic scheme for the preparation of APPD is shown in Fig.1. The key intermediate,
cis-diol pyrrolidine, was derived from (3R,4S)-1-benzyl-3,4-dihydroxypyrrolidine-2,5-dione
1, which was prepared by the OsO4-catalyzed enantioselective dihydroxylation of N-benzyl
maleimide [31]. 1 was protected with 2,2-dimethyloxypropane, which was sequentially
reduced by LiAlH4 at 80°C and by hydrogenation over 20% Pd hydroxide/C catalyst to
remove the benzyl group, affording the protected pyrrole 4. The crude product 4 was
purified by precipitating its hydrochloride salt in ether and the overall yield of the first four
steps was 33%. Product 4 was treated with 4-cyanobenzene-1-sulfonyl chloride to give 5 in
87% yield. The conversion of 5 to the target molecule 6 was achieved by the hydrogenation
over 10% Pd/C catalyst in methanol, containing 2% of acetic acid. The deprotection of cis-
diol with 2.0 M HCl solution afforded the target compound 6.
Fluorogenic derivatization of 3-NT containing peptides with APPD
The reaction sequence for the fluorogenic derivatization of a 3-AT containing peptide with
APPD is shown in Figure 2, in accord with the published reaction scheme for benzylamine
[15]. Prior to fluorescent tagging, 3-NT-containing peptides (mass shift of +45 amu relative
to Tyr) are completely reduced by 10 mM sodium dithionite to respective 3-AT-containing
sequences (mass shift of +15 relative to Tyr) as confirmed by MS analysis (data not shown).
Concentrations of reagents for fluorogenic derivatization were optimized based on yields of
fluorescent products assessed by fluorescence spectrometry. For a 3-NT concentration of 5
µM, an increase of APPD concentration over 10 mM (i.e. at more than 1000-fold molar
excess of the reagent) did not significantly affect the yield of a fluorescent product with
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maximum emission at 510 nm and excitation maximum at 360 nm (data not presented). A
concentration dependence of the fluorescence intensity at 510 nm on the concentration of
oxidant, K3Fe(CN)6, showed a saturation behavior at ca. 100 µM (Figure 3A). Tagging
FSAY(3-NH2)LER with 10 mM APPD and 100 µM K3Fe(CN)6 resulted in a nearly linear
dependence of the fluorescence intensity at 510 nm on the peptide concentration between 0
and 20 µM (Fig. 3, B and C). MALDI-TOF MS analysis (Fig. 4A) shows that APPD tagging
produced two major benzoxazole products of the peptide with m/z 1421.9 (product I) and
1166.8 (product II), which correspond to peptide derivatives of +536 and +281 amu,
respectively. The respective structures for these products are displayed in the inserts of
Figures 5A and 5B. LC-MS/MS analysis confirmed that in the sequence of tagged peptides
these characteristic mass shifts located on the Tyr residue, Tyr+536 and Tyr+281,
respectively, based on the mass difference between the y4 and y3 fragments in the spectra
(Fig.5, A and B). Here, the addition of APPD and ammonia, respectively, to the 6-position
of the benzoxazole ring is suggested based on previous structural analysis of benzylamine
reaction with 4-methylcatechol [14]. Importantly, no significant remaining amounts of
FSAY(3-NH2)LER (m/z 900.5) or FSAY(3-NO2)LER (m/z 930.4) were observed after the
reaction. A small yield (ca. 7%) of a product with m/z 1149.8 (product III) was observed in
the MALDI-TOF MS spectrum (Fig. 4A). This mass is consistent with the intramolecular
addition of the N-terminal amino group to position 6 in the final benzoxazole, a hypothetical
structure of which is shown in the insert of Fig.5C, and based on the observed MS/MS
fragmentation pattern. Analogous products have been observed upon derivatization of 3-AT-
containing peptides with 4-(aminomethyl)benzenesulfonic acid (ABS) [32]. Importantly,
product III will contribute to the total fluorescence at 510 nm and nearly co-elutes with
products I and II in the reverse-phase chromatogram (HPLC fractions collected between 26
and 29 min in Fig. 4B), confirmed by capLC-FT-ICR-MS analysis (data not shown).
In addition to the 510-nm fluorescence (benzoxazole), fluorescence spectrometry detected
the formation of another fluorescent species with an emission maximum at ca. 430 nm,
which is also present in the control samples (reagents without peptide; spectra in Fig. 3C).
We did not focus on the identification of fluorescent side products in this study; however,
reverse-phase HPLC shows the presence of several fluorescent peaks besides the major peak
with a retention time of ca. 27 min., which appear at increasing concentrations of the
oxidant, K3Fe(CN)6 (compare chromatograms 1 and 2 in Fig.4B). This is the reason to use
relatively low concentrations of the oxidant (not more than 100 µM; see Fig.3A) particularly
at 3-NT concentrations below 1 µM. These results are in accord with our previous study on
3-AT tagging with an other benzylamine derivative, ABS, where we have determined that
maximum yields of benzoxazole product can be achieved at a ratio of K3Fe(CN)6 to 3-AT of
ca. 5 to 1 and that a further increase in the oxidant concentration results mostly in
fluorescent side product formation [32]. The background fluorescence after tagging with
ABS was attributed to the reagent background and, potentially, to the formation of protein
oxidation products during the course of the derivatization procedure. Irrespective of its
nature, the relative contribution of this background fluorescence is higher at lower
concentrations of nitropeptides, which defines a detection limit of about 0.1 µM 3-NT by
fluorescence spectrometry [32]. However, specifically for APPD tagging, we have the
unique opportunity to separate the APPD tagged peptides from fluorescence side products
by boronic acid affinity chromatography, and to monitor them by their specific fluorescence
at 510 nm.
Boronate affinity separation and enrichment of a fluorescent APPD-tagged synthetic
model peptide
The synthetic APPD reagent contains two separate functional groups: the benzylamine
group for formation of fluorescent benzoxazole and the cis-diol group, which associates in a
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pH-dependent manner with boronate anion. The latter properties can be utilized for
enrichment of the APPD-derivatized 3-NT peptides by boronate affinity chromatography.
We first tested the boronate affinity enrichment of an APPD-tagged model peptide on a
modified silica solid phase containing a sulfonamide-substituted phenylboronic acid with a
boronate pKa of 7.5 [25]. This solid phase displays an enhanced boronate binding of alkyl-
and aryl-cis-diol compounds under neutral conditions. Fig. 6A shows the boronate affinity
HPLC with fluorescence detection at 510 nm of APPD-tagged FSAY(3-NO2)LER using a
column (4.6 i.d. × 50 mm length) packed with the synthetic sulfonamide-substituted
phenylboronic acid. The APPD-tagged peptide was bound to the column in 50 mM
NH4HCO3 buffer (pH 7.8) and washed for 10 min (at 1 ml/min) with this buffer.
Subsequently, the tagged peptide was eluted with water (pH~5.8) during the next 10 min
(trace 1 in Fig.6A). Further acidification of the elution buffer is not necessary, since it does
not yield greater amounts of APPD-tagged peptides but requires additional efforts to clean
up samples for subsequent MS analysis. To account for non-specific binding to the column
material due to hydrophobic interactions, increasing concentrations of ACN were added to
both binding and elution buffers. We found that the addition of 30% (v/v) ACN effectively
blocks non-specific affinity during both washing and elution steps (Fig. 6A, trace 3).
Without organic solvent a significant accumulation of the fluorescent peptide occurs on the
column, which can be washed out by 30% ACN in the mobile phases during a subsequent
blank run (trace 2 in Fig.6A). The fluorescent fractions eluting after acidification (between
13 and 18 min) were collected and analyzed by MALDI-TOF MS (Fig. 7A) and capLC-FT-
ICR-MS (Fig.7, B and C), which confirmed that the eluate contained predominantly APPD-
tagged FSAY*LER in the form of products I (m/z 1421.97) and II (m/z 1166.83) (the
respective structures are shown in the inserts of Fig. 5A and 5B). It appears that both APPD
derivatives of FSAY*LER, containing either one or two cis-diol groups, have a comparable
affinity to the column based on a comparable abundance of the respective peptide ions in the
MALDI mass spectrum (Fig. 7A).
Qualitative enrichment of nitrated peptides from a biological matrix
It is well recognized that the presence of biological matrix may interfere with and even
completely block both the specific chemical derivatization of low-abundant analytes and
subsequent LC and MS analysis [33]. We tested our APPD derivatization approach using
small aliquots of in vitro nitrated protein, Ph-b, mixed with 100–1000 fold excess of proteins
derived from C2C12 cultured cells to obtain levels of 100 to 2000 pmol protein-bound 3-NT
per mg total protein in the mixture. In terms of molar ratios, the amount of 100 pmol 3-NT/
mg protein would represent average Tyr nitration levels of 0.005 mol 3-NT per mol of
protein with an average molecular weight of 50 kDa. That is, statistically in these mixtures
only one out of 200 proteins would contain a nitrated Tyr residue, and each nitrated protein
would yield only one nitropeptide but, on average, 50–100 non-nitrated peptides upon
tryptic digestion. Fig. 6B shows that a protein digest containing 1 µg (~10 pmol) of nitrated
Ph-b and 100 pmol of 3-NT can be derivatized with APPD to yield a fluorescent product
with a 510 nm emission maximum, which is successfully enriched by boronic affinity
chromatography and detected by its specific fluorescence. Importantly, the presence of an
excess amount of non-nitrated peptides (trypsin digests from 0.2 to 1 mg C2C12 proteins)
did not reduce the yield of fluorescent benzoxazole products based on the 510-nm
fluorescence.
Additional proof for the specific binding of 510-nm fluorescent products (benzoxazole) to
the boronate column was obtained through a proteomic analysis of non-retained peptides
(HPLC fractions from 1 to 10 min), and more tightly retained peptides (13–18 min) as
shown in Fig. 8. In this experiment, slightly higher amounts of nitrated Ph-b (5 µg) were
used to obtain a better coverage of Ph-b peptides. The boronate affinity chromatograms after
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APPD derivatization of nitrated Ph-b digest alone and in the presence of 0.2 mg protein
digest from C2C12 cells show significant differences in matrix peptide content in both
fractions based on 280-nm absorbance (traces 1 and 2 in Fig.8B, respectively), but no
changes in the yield of fluorescent products in the boronate affinity fractions based on
specific 510-nm fluorescence detection (traces 1 and 2 in Fig. 8A). CapLC-FT-ICR-MS
analysis followed by Sequest search against mouse and rabbit protein databases, identified
native peptides from more than 200 mouse proteins (not shown) and multiple native but no
APPD tagged rabbit Ph-b peptides in the flow-through (1–10 min) fractions (Fig. 9A). In
contrast, the fluorescent boronate affinity chromatographic fractions contained only APPD-
tagged peptides from the rabbit Ph-b sequence (Fig.9B).
The specific enrichment of APPD-tagged peptides via boronate affinity chromatography can
be demonstrated by comparative analysis of the chromatograms obtained for nitropeptides
tagged with either APPD or ABS, which differs from APPD by the lack of the cis-diol
pyrrolidine ring. Tagging with ABS results in the formation of a fluorescent derivative with
maximum emission at 480 nm and ca. two-fold higher chemical and/or fluorescence
quantum yields as compared with APPD (Fig. 10A), in accord with our previous results
[32]. The ABS derivatives did not bind to the column and eluted during the washing step
immediately after injection unlike the APPD derivatives (Fig. 10B). These results clearly
demonstrate the significance of the cis-diol group in the APPD reagent for boronate affinity
enrichment. For comparison of our synthetic sulfonamide-substituted phenylboronic acid,
the boronate affinity chromatography of the APPD-tagged peptides was conducted on a
commercially available column (TSK-Gel Boronate-5PW 1000A, 10µ, 7.5 mm i.d. × 75 mm
length) containing immobilized m-aminophenylboronic acid, under the same HPLC
conditions. This column displayed a similar affinity for the APPD-tagged peptides from
C2C12 protein digests as our synthetic column (data not presented) providing additional
evidence for the role of pH-dependent complex formation between the APPD cis-diol
function and the boronate anion of the stationary phase.
Quantitative analysis of APPD-tagged 3-NT in complex peptide mixtures from proteins
nitrated in vitro by boronate affinity chromatography with fluorescence detection
In the previous section, we had tested the qualitative enrichment of APPD-tagged peptides
from a complex biological matrix. To test whether boronate affinity chromatography of
APPD-tagged nitropeptides may represent a quantitative method to analyze low levels of
protein tyrosine nitration in complex peptide mixtures, we nitrated Ph-b by peroxynitrite in
vitro and mixed with an excess of proteins from lysate of C2C12 cultured cells. 3-NT
concentrations were quantified through specific 430-nm absorbance as described in the
experimental section. After trypsin digestion, reduction of 3-NT with sodium dithionite, and
derivatization with APPD as described above, samples were separated by boronate affinity
chromatography and detected through the specific fluorescence of APPD-tagged peptides
(excitation and emission wavelengths of 360 and 510 nm, respectively). The dependence of
the peak areas on the original concentration of 3-NT is shown in Fig. 11A. Importantly, the
results are presented for relatively low, biologically relevant 3-NT concentrations (below 1
µM) in the presence of highly abundant non-nitrated peptides (digest of 1 mg total protein
from C2C12 cultured cell lysate). A linear regression analysis gave the limit of detection
(LOD) of ca. 68 nM of 3-NT, corresponding to 13 pmol of 3-NT per injection. This value is
lower than the LOD for fluorescence spectrometry analysis alone, 95 nM of 3-NT (19 pmol
per sample) (Fig. 11B). Although the calculated values for APPD tagging are comparable to
those reported for ABS tagging (0.09 µM and 40 pmol 3-NT [32]), quantitation through
APPD tagging/boronate affinity chromatography can be performed in the presence of at
least 10-fold larger amounts of biological matrix (1 mg in the case of APPD vs 100 µg for
ABS). This feature offers an opportunity of enrichment and accumulation of APPD-tagged
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peptides from large amounts of biological material that is very important, particularly, for
sequence-specific analysis of low abundant protein nitration in tissues.
Sequence-specific characterization of protein Tyr nitration by fluorogenic tagging with
APPD and boronate affinity chromatography enrichment of tagged peptides
To test whether low-level protein tyrosine nitration in complex protein mixtures can be
assessed in a sequence-specific matter, we analyzed by capLC-FT-ICR-MS the fluorescent
boronate affinity fractions of APPD-tagged peptides from peroxynitrite exposed C2C12
cells. Protein nitration was achieved at a level of ca. 1 nmol 3-NT per 0.5 mg total protein.
The efficiency of APPD tagging/boronate affinity enrichment was addressed through
comparison of capLC-FT-ICR-MS data with those for non-tagged or ABS-tagged samples
prepared from the same amount of material in similar conditions except for affinity
separation of tagged peptides. Analysis of non-tagged or ABS-tagged nitrated C2C12
protein digests identified >100 proteins at highest probability settings; no ABS-tagged
peptides were revealed (data not shown). In contrast, APPD-tagging/boronate affinity
enrichment resulted in the detection of two APPD tagged peptides (Tyr +536 amu),
indicating two tyrosine nitration sites in the sequence of mouse actin 1 (Fig.12, A and B).
Importantly, no non-tagged peptides from actin 1 (Fig. 12, C) or other proteins (data not
shown) can be identified in the samples after boronate affinity enrichment, in contrast to
non-purified sample (Fig. 12, D). Since the yields of fluorescent benzoxazole products are
higher in the ABS tagged samples (Fig. 10A), our data suggest that for successful sequence-
specific characterization of tagged 3-NT the absolute amounts of an analyte, which is tagged
3-NT, are less important than the relative abundance in the sample. Therefore, our approach
of APPD tagging/boronate affinity enrichment of nitropeptides, in addition to accumulation
of APPD-tagged peptides from larger amounts of biological material, offers the option of a
removal of non-tagged matrix peptides, which suppress the sequence-specific MS analysis
of low abundant protein tyrosine nitration.
Discussion
In this study, a novel chemical tagging reagent, APPD, was synthesized and applied to
fluorogenic derivatization and boronate affinity enrichment of 3-NT-containing peptides.
Based on the derivatization of a synthetic peptide, FSAY(3-NO2)LER, we established a
tagging protocol optimized for maximum yields of fluorescence benzoxazole derivatives
from 3-NT. Though different fluorescent products of APPD-tagged 3-NT peptides are
detected by MS analysis, with different substitutions in position 6 of the benzoxazole, they
all contain the 2-benzoxazole core and contribute to the measured fluorescence with
emission maximum at 510 nm and excitation maximum at 360 nm. Fluorescent 2-
benzoxazole derivatives are formed via condensation with the benzylamine moiety of APPD
specifically from protein/peptide 3-AT, and, potentially, from 3-hydroxytyrosine (DOPA)
[14,15] and 5-hydroxytryptophan [32], two another important biomarkers of oxidative
protein modification. The latter two species do not require a reduction step to form
benzoxazole upon tagging with benzylamines [14], and can be fluorometrically assessed
separately from 3-NT provided that the respective non-reduced controls are included. In our
experiments with C2C12 cells exposed to peroxynitrite we did not observe significant
amounts of fluorescence products emitting at 510 nm in non-reduced samples. However,
unidentified fluorescent side products with an emission maximum at 430 nm may also form
from APPD irrespective of the presence of 3-NT that causes detection limits of 95 and 68
nM, respectively, for fluorescence spectroscopy and boronate affinity HPLC-FL analysis of
APPD tagged 3-NT. These numbers are better than those previously reported for fluorogenic
3-NT tagging with ABS, which lacks the affinity functionality [32]. The critical advantage
of APPD tagging/boronate affinity enrichment is that APPD-tagged peptides will be
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separated from non-tagged material and eluted virtually in a single peak. Therefore, our
approach offers a possibility for the accumulation of APPD tagged 3-NT peptides for both
quantitative fluorescence spectrometry and sequence-specific MS analysis provided that the
amount of material is not limited (this is a common situation in studies of tissue biomarkers)
suggesting its potential application in the characterization of protein nitration in complex
biological systems.
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Synthesis of APPD. Reagents and conditions: (a) OsO4, NMO, H2O/acetone (5:1 v/v), 50
°C; (b) 2,2-dimethyloxypropane/TyOH; (c) LiAlH4, THF, 80 °C; (d) H2, Pt/C, MeOH; (e) 4-
cyanobenzene-1-sulfonyl chloride, Et3N, MeCN; (f) H2, Pt/C, MeOH, 10% conc. HCl.
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Derivatization pathway of peptide 3-AT with APPD.
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The dependences of fluorescence intensity after tagging of FSAY(3-NO2)LER with APPD
on the concentration of K3Fe(CN)6 (A) or 3-NT peptide (B) and fluorescence spectra at
different concentrations of 3-NT (C). A - FSAY(3-NO2)LER (5 µM) was reduced to
FSAY(3-NH2)LER and incubated with 10 mM APPD and different concentrations of
K3Fe(CN)6 in 0.1 M sodium phosphate buffer (pH 9.0) for 1 h. B and C - Fluorescence
intensities and spectra, respectively, at different concentrations of the 3-NT peptide tagged
with 10 mM APPD and 100 µM K3Fe(CN)6 as described above. Fluorescence was
measured in a 0.5-mL (1-cm) cuvette using excitation and emission wavelengths of 360 and
510 nm, respectively.
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Analysis by MALDI-TOF MS (A) and reverse-phase HPLC detected by fluorescence (B) of
APPD-tagged FSAY(3-NO2)LER. After reduction of 3-NT to 3-AT the peptide (10 µM)
was incubated for 1 h with 10 mM APPD and 20 µM (curve 1) or 100 µM (curve 2) of
K3Fe(CN)6 in 0.1 M sodium phosphate buffer (pH 9.0) at room temperature.
Chromatograms were detected using excitation and fluorescence wavelengths of 360 and
510 nm, respectively.
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ESI-MS/MS identification of different benzoxazole products after nitro-to-amino reduction
of FSAY(3-NO2)LER (10 µM) and tagging with 10 mM APPD and 100 µM K3Fe(CN)6.
The structures shown in inserts contain different substitutions in position 6 of the original 3-
NT ring (the fluorescent 2-phenylbenzoxasole core is circled).
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Boronic affinity chromatography of APPD tagged synthetic peptide (A) and of tryptic digest
of nitrated rabbit phosphorylase b mixed with proteins from lysate of C2C12 cultured cells
(B) detected by fluorescence (excitation and emission wavelengths are 360 and 510 nm,
respectively). In panel A, 200 µL of 10 µM FSAY(3-NO2)LER after reduction of 3-NT to 3-
AT and incubation with 10 mM APPD and 100 µM K3Fe(CN)6 for 1 h was injected onto
phenylboronic column equilibrated with buffer A containing 50 mM NH4HCO3 (pH 7.8) in
the absence (1) or presence (2 and 3) of 30% (v/v) acetonitrile. The arrow indicates
switching from buffer A to water in the mobile phase without changing the percentage of
organic solvent. Trace 2 represents a blank injection (washing run) after the separation
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performed in the absence of organic solvent (trace 1). Panel B: Boronic affinity separation of
tryptic peptides from nitrated Ph-b (1 µg protein containing 100 pmol 3-NT) only (trace 1)
and in the presence of C2C12 cell proteins (trace 2 – 0.2, trace 3 – 0.5, and trace 4 – 1 mg
total protein) reduced and tagged in the same conditions.
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Analysis of fluorescent boronate affinity HPLC fractions (13–18 min. in chromatogram 3,
Fig.6A) by MALDI-TOF (A) and capLC-FT-ICR MS (B and C). B and C represent tandem
MS spectra for APPD-tagged FSAY*LER ions with mass shifts of Y+536 (m/z 1421.5) and
Y+281 (m/z 1166.6), respectively, present in panel A.
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Boronate affinity chromatography of model nitrated protein, Ph-b, mixed with high amounts
of C2C12 cell lysate protein, through APPD tagging of digested proteins and detected by
specific fluorescence (A) or 280-nm absorbance (B). Nitrated Ph-b (5 µg) was analyzed
either alone (trace 1) or in the presence of 0.2 mg C2C12 proteins (trace 2); trace 3
represents a reagent control (APPD tagging in the absence of 3-NT). 3-NT containing
peptides were reduced to corresponding 3-AT peptides and tagged with 10 mM APPD and
50 µM K3Fe(CN)6 in 0.2 M NH4HCO3 (ABC) buffer at pH 9, bound to boronate affinity
column in 0.1 M ABC buffer at pH 7.8 (0–10 min) and eluted with H2O at pH 5.8 (10–20
min) at a flow rate of 1 ml/min. Boronate affinity (13–18 min) and flow-through fractions
(1–10 min) were collected for LC-MS analysis.
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Sequence coverage for Ph-b in flow-through (A) and boronate affinity (B) fractions
collected during chromatographic run shown in Fig.8 (trace 2). In panel B, APPD
derivatization products detected in the sample (Y+536, Y+ 264, and Y+281) are shown in
bold, italic and underlined font, respectively.
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Comparison of fluorescence spectra (A) and boronate affinity chromatographic runs
detected by fluorescence (B) of nitrated C2C12 cultured cell protein digests (250 µg total
protein containing 500 nmol 3-NT), reduced with 20 mM sodium dithionite and tagged with
10 mM of either APPD (solid lines) or ABS (dotted lines) and 100 µM K3Fe(CN)6 in 100
mM PBS (pH 9.0). Chromatographic conditions were as in the legend to Fig.8.
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Validation of the fluorogenic APPD derivatization as quantitative method for peptide 3-NT
determination by boronate affinity chromatography with fluorescence detection (A) and by
fluorescence spectrometry (B). 3-NT concentration in samples (0–1 µM) was achieved
through addition of different amounts of nitrated Ph-b, containing ca. 10 mol 3-NT/mol
protein (1 µM 3-NT/2.5 µg Ph-b), to 0.5 mg of C2C12 cell lysate protein. Samples were
digested with trypsin, reduced by 10 mm sodium dithionite and derivatized with 2 mM
APPD and 20 µM K3Fe(CN)6 in 50 mM ammonium bicarbonate buffer (pH 9.0). Boronate
affinity chromatography conditions were as in the legend to Fig. 8.
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Representative capLC-FT-ICR tandem MS spectra of APPD-tagged peptides in the protein
tryptic digest from peroxynitrite-exposed C2C12 cells, obtained after boronate affinity
enrichment of a sample contained 1 nmol 3-NT in 500 µg of protein. A and B represent
tandem MS spectra of two peptides, SY*ELPDGQVITIGNER and QEY*DESGPSIVHR
(mass shift on both of +536 relative to Tyr), from the sequence of mouse cytoplasmic actin 1
(gene name: actb). Protein sequence coverage is shown in panel C; for comparison, panel D
shows sequence coverage for this protein observed without APPD tagging and boronate
affinity enrichment.
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